Tandem Diabetes Care

Tandem Diabetes Care, Inc. is a San Diego based medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. Our first product, the t:slim® Insulin Pump, features a sleek, modern design, intuitive touch-screen interface, and a rechargeable lithium polymer battery. We are committed to fostering an open, collaborative environment and hiring passionate, dedicated employees in order to achieve our goal of being a diabetes industry leader.
San Diego, US
Size (employees)
591 (est)+23%
Tandem Diabetes Care is headquartered in San Diego, US

Key People at Tandem Diabetes Care

Kim D. Blickenstaff

Kim D. Blickenstaff

President , CEO & Board Of Director
John Cajigas

John Cajigas

Jim Leal

Jim Leal

VP, Operations
Bob Anacone

Bob Anacone

EVP and Chief Commercial Officer
Susan Morrison

Susan Morrison

VP, HR, Corporate & Investor Relations

Tandem Diabetes Care Office Locations

Tandem Diabetes Care has an office in San Diego
San Diego, US (HQ)
11045 Roselle St

Tandem Diabetes Care Data and Metrics

Tandem Diabetes Care Financial Metrics

Tandem Diabetes Care's revenue was reported to be $84.2 m in FY, 2016 which is a 16% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

84.2 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

23.6 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(83.4 m)

EBIT (FY, 2016)

(78.1 m)

Market capitalization (31-May-2017)

39.6 m

Closing share price (31-May-2017)


Cash (31-Dec-2016)

44.7 m


73.9 m
Tandem Diabetes Care's current market capitalization is $39.6 m.
FY, 2014FY, 2015FY, 2016


49.7 m72.9 m84.2 m

Revenue growth, %


Cost of goods sold

34.5 m46.3 m60.7 m

Gross profit

15.2 m26.6 m23.6 m

Gross profit Margin, %


Operating expense total

90.9 m95.6 m101.6 m


(75.7 m)(69 m)(78.1 m)

EBIT margin, %


Net Income

(79.5 m)(72.4 m)(83.4 m)
FY, 2014FY, 2015FY, 2016


31.2 m43.1 m44.7 m

Accounts Receivable

7.7 m14.1 m11.2 m


11.9 m17.5 m21.2 m

Current Assets

90.8 m107 m92.1 m


12.6 m15.5 m18.4 m

Total Assets

106.5 m125.1 m112.4 m

Accounts Payable

1.9 m5.2 m7.5 m

Total Debt

29.4 m29.3 m79 m

Current Liabilities

18.1 m26.5 m31.5 m

Non-Current Liabilities

33.8 m34.7 m86.8 m

Total Liabilities

51.9 m61.3 m118.3 m

Additional Paid-in Capital

303.3 m384.6 m398.6 m

Retained Earnings

(248.7 m)(321.1 m)(404.6 m)

Total Equity

33.8 m63.5 m(5.9 m)

Debt to Equity Ratio

0.9 x0.5 x-13.3 x

Debt to Assets Ratio

0.3 x0.2 x0.7 x

Financial Leverage

3.2 x2 x-19 x
FY, 2014FY, 2015FY, 2016

Net Income

(79.5 m)(72.4 m)(83.4 m)

Depreciation and Amortization

4.4 m4.8 m5.5 m

Accounts Receivable

(2.5 m)(6.5 m)2.3 m


(1.8 m)(6.1 m)(6.9 m)

Accounts Payable

(1.2 m)3.4 m3.2 m

Cash From Operating Activities

(61.4 m)(58.8 m)(61.2 m)

Purchases of PP&E

(4.4 m)(5.8 m)(8.9 m)

Cash From Investing Activities

(35.5 m)2.4 m10.4 m

Short-term Borrowings

(30 m)

Cash From Financing Activities

3.6 m68.3 m52.3 m

Interest Paid

3.4 m3.3 m4.4 m

Income Taxes Paid

71 k9 k23 k
Y, 2016


-0.9 x


-1.2 x


-13.3 x


0.7 x

Financial Leverage

-19 x

Tandem Diabetes Care Operating Metrics

Tandem Diabetes Care's Devices Sold was reported to be 50 k in FY, 2016
FY, 2016

Devices Sold

50 k

Patents Issued


Patents Pending




Tandem Diabetes Care Market Value History

Tandem Diabetes Care Online and Social Media Presence

Tandem Diabetes Care Company Life and Culture

You may also be interested in